Non-Small Cell Lung Carcinoma
Item
patients with histological confirmation of non-small-cell lung carcinoma.
boolean
C0007131 (UMLS CUI [1])
Disease Complete excision
Item
complete surgical resection of the disease.
boolean
C0012634 (UMLS CUI [1,1])
C0015250 (UMLS CUI [1,2])
Tumor tissue Available Molecular Analysis
Item
tumoral tissue available for molecular analysis.
boolean
C0475358 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C1513380 (UMLS CUI [1,3])
Lymph Node Involvement TNM clinical staging
Item
n1 (stage ii) or n2 (stage iiia) lymph node involvement in the study of the operative piece.
boolean
C0806692 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Age
Item
men or women age 18 years or older.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
patients with a performance status of 2 or less according to the ecog classification.
boolean
C1520224 (UMLS CUI [1])
Laboratory Results | Absolute neutrophil count | Hemoglobin measurement | Platelet Count measurement | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Creatinine clearance measurement
Item
patients with the following laboratory results: anc < 1500/l, hb < 10 g/dl, platelets <100,000/l, bilirubin < 1.0 mg/dl, ast and alt < 1.5 upper limit of normality, creatinine clearance < 60 ml/min.
boolean
C1254595 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C1278039 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C0201836 (UMLS CUI [7])
C0373595 (UMLS CUI [8])
Operative Surgical Procedures Complete Recovery
Item
complete recovery from surgery within 6 weeks.
boolean
C0543467 (UMLS CUI [1,1])
C2826210 (UMLS CUI [1,2])
Informed Consent
Item
patients who have given written informed consent before initiating any specific study screening procedure.
boolean
C0021430 (UMLS CUI [1])
Chemotherapy Study Disease | Therapeutic radiology procedure Study Disease
Item
patients who have received previously chemotherapy or radiotherapy for the study disease.
boolean
C0392920 (UMLS CUI [1,1])
C2603343 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C2603343 (UMLS CUI [2,2])
C0012634 (UMLS CUI [2,3])
Chemotherapy | Compliance behavior Unsuccessful Due to Cultural reasons | Compliance behavior Unsuccessful Due to Geographic Factors
Item
impossibility of complying with chemotherapy treatment due to cultural or geographic circumstances.
boolean
C0392920 (UMLS CUI [1])
C1321605 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])
C0678226 (UMLS CUI [2,3])
C3841422 (UMLS CUI [2,4])
C1321605 (UMLS CUI [3,1])
C1272705 (UMLS CUI [3,2])
C0678226 (UMLS CUI [3,3])
C0017444 (UMLS CUI [3,4])
Communicable Disease | Heart Disease | Disease Serious
Item
patients with active infection, heart disease, or any other serious disease, in the judgment of the investigator.
boolean
C0009450 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0012634 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
women who are pregnant or in the period of lactation.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Malignant Neoplasms | Exception Carcinoma in situ of uterine cervix | Exception Skin carcinoma
Item
patients with a previous diagnosis of malignant disease in the last five years except for carcinoma in situ of the uterine cervix or skin cancer other than melanoma.
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0851140 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0699893 (UMLS CUI [3,2])
Investigational New Drugs
Item
patients under treatment with investigational agents.
boolean
C0013230 (UMLS CUI [1])